Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc.
Alpha Tau Medical LTD.
Iovance Biotherapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Institute of Oncology Ljubljana
Memorial Sloan Kettering Cancer Center
Intergruppo Melanoma Italiano
Medicenna Therapeutics, Inc.